PMC:7321036 / 46121-46334
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T370","span":{"begin":23,"end":28},"obj":"Body_part"},{"id":"T371","span":{"begin":112,"end":119},"obj":"Body_part"}],"attributes":[{"id":"A370","pred":"fma_id","subj":"T370","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A371","pred":"fma_id","subj":"T371","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"(C) As in (B). Vero E6 cells were treated with the CK2 inhibitor silmitasertib. Physical interactions between N protein and the CSNK2A2 and CSNK2B CK2 subunits were observed in a prior study (Gordon et al., 2020)."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T563","span":{"begin":11,"end":12},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T564","span":{"begin":15,"end":28},"obj":"http://purl.obolibrary.org/obo/CLO_0051719"},{"id":"T565","span":{"begin":177,"end":178},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"(C) As in (B). Vero E6 cells were treated with the CK2 inhibitor silmitasertib. Physical interactions between N protein and the CSNK2A2 and CSNK2B CK2 subunits were observed in a prior study (Gordon et al., 2020)."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T321","span":{"begin":55,"end":64},"obj":"Chemical"},{"id":"T322","span":{"begin":112,"end":119},"obj":"Chemical"}],"attributes":[{"id":"A321","pred":"chebi_id","subj":"T321","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A322","pred":"chebi_id","subj":"T322","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"(C) As in (B). Vero E6 cells were treated with the CK2 inhibitor silmitasertib. Physical interactions between N protein and the CSNK2A2 and CSNK2B CK2 subunits were observed in a prior study (Gordon et al., 2020)."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"942","span":{"begin":128,"end":135},"obj":"Gene"},{"id":"943","span":{"begin":110,"end":111},"obj":"Gene"},{"id":"944","span":{"begin":65,"end":78},"obj":"Chemical"},{"id":"945","span":{"begin":20,"end":22},"obj":"CellLine"}],"attributes":[{"id":"A942","pred":"tao:has_database_id","subj":"942","obj":"Gene:1459"},{"id":"A943","pred":"tao:has_database_id","subj":"943","obj":"Gene:43740575"},{"id":"A945","pred":"tao:has_database_id","subj":"945","obj":"CVCL:4582"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"(C) As in (B). Vero E6 cells were treated with the CK2 inhibitor silmitasertib. Physical interactions between N protein and the CSNK2A2 and CSNK2B CK2 subunits were observed in a prior study (Gordon et al., 2020)."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T306","span":{"begin":0,"end":14},"obj":"Sentence"},{"id":"T307","span":{"begin":15,"end":79},"obj":"Sentence"},{"id":"T308","span":{"begin":80,"end":213},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"(C) As in (B). Vero E6 cells were treated with the CK2 inhibitor silmitasertib. Physical interactions between N protein and the CSNK2A2 and CSNK2B CK2 subunits were observed in a prior study (Gordon et al., 2020)."}